Daily Market News
Daily Stock Markets News
Cannot fetch data from server.

Autoimmune Disease Diagnostics Market Size is expected to

BEIJING, Nov. 28, 2022 (GLOBE NEWSWIRE) — The Global Autoimmune Disease Diagnostics Market Size accounted for USD 4.4 Billion in 2021 and is projected to occupy a market size of USD 8.2 Billion by 2030 growing at a CAGR of 7.2% from 2022 to 2030.

Autoimmune Disease Diagnostics Market Statistics

  • Global autoimmune disease diagnostics market revenue was worth USD 4.4 billion in 2021, with a 7.2% CAGR from 2022 to 2030
  • North America region was accounted 34.9% of autoimmune disease diagnostics market share in 2021
  • Asia-Pacific autoimmune disease diagnostics market growth is expected to expand at a CAGR of 8% from 2022 to 2030
  • By end-use, hospitals sector capture over 52.2% of total market share in 2021
  • Rising adoption of lab automation technologies, drives the autoimmune disease diagnostics market value

Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/1177

Autoimmune Disease Diagnostics Market Report Coverage:

Market Autoimmune Disease Diagnostics Market
Autoimmune Disease Diagnostics Market Size 2021 USD 4.4 Billion
Autoimmune Disease Diagnostics Market Forecast 2030 USD 8.2 Billion
Autoimmune Disease Diagnostics Market CAGR During 2022 – 2030 7.2%  
Autoimmune Disease Diagnostics Market Analysis Period 2018 – 2030
Autoimmune Disease Diagnostics Market Base Year 2021  
Autoimmune Disease Diagnostics Market Forecast Data 2022 – 2030
Segments Covered By Product, By Test Type, By End-Use, And By Geography
Autoimmune Disease Diagnostics Market Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled AstraZeneca, Inova Diagnostics Inc., Novartis AG, Abbott Laboratories, Pfizer Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories Inc., Hemagen Diagnostics Inc., Beckman Coulter Inc. and Sanofi-aventis.
Report Coverage Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Autoimmune Disease Diagnostics Market Overview

Autoimmune illnesses are caused by the body’s unique immunological responses, which result in antibodies that target its own tissues and cells. Normally, this results in the breakdown and weakening of healthy tissues. Some of the procedures used to diagnose autoimmune disease include the autoantibody test, antinuclear antibody measure, complete blood count, erythrocyte sedimentation rate, as well as C-reactive protein.

Autoimmune Disease Diagnostics Market Trends

Increasing disease occurrences, rising demand for better and more accurate diagnostic procedures, rising adoption of advanced rapid recognition, various development activities, and initiatives taken by favorable federal regulations are some of the key factors driving the global autoimmune disease diagnostics market growth. North America is expected to develop at the fastest rate during the forecast period due to the availability of a wide range of improved and more precise disease diagnostic procedures, early acceptance of various sophisticated diagnostic techniques, with continuing technological developments in the healthcare sector. Awareness campaigns organized by various organizations are also contributing significantly to the expansion of the geographical autoimmune disease diagnostics market.

Rising Disease Incidence and Demand for More Accurate Diagnostic Procedures to Drive Global Autoimmune Disease Diagnostics Market Growth

Rising incidences of conditions such as Hashimoto’s thyroiditis and rheumatoid arthritis, as well as various governmental efforts, are some of the primary drivers driving the worldwide autoimmune disease diagnostics market growth. In accordance with the American Autoimmune Related Diseases Association, approximately 50 million individuals across the globe are currently affected by autoimmune disorders. Over the projected period, this aspect is expected to generate the enormous potential for the worldwide autoimmune disease diagnostics market. The rising demand for better and more accurate diagnostic processes as the incidence of various illnesses rises is expected to drive the use of autoimmune disease diagnostic techniques over the projected timeframe. Autoimmune disorders are still poorly understood. The government is funding extensive research and development operations in order to produce superior diagnostic and treatment procedures. Such research endeavors are projected to boost market expansion even more. Several measures to reduce the cost of curing these disorders are also expected to boost overall market growth throughout the predicted period. Currently, organizations such as Johns Hopkins and the Autoimmune Research Network (ARNet) Autoimmune Disease Research Centre are conducting research in this area. These organizations are primarily focused on the creation of various ways to…

Read More: Autoimmune Disease Diagnostics Market Size is expected to

Notify of
Inline Feedbacks
View all comments

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.